Back to the search results

Universitätsklinikum Tübingen

Geissweg 3
72076 Tübingen

Phone: 07071-29-0
Fax: 07071-29-3966
Mail: ed.negnibeut-inu.dem@ecivres

  • Number of beds: 1.618
  • Number of specialist departments: 37
  • Number of inpatient cases: 66.448
  • Number of partial inpatient cases: 5.845
  • Number of outpatient cases: 976.024
  • Number of cases of inpatient-equivalent psychiatric treatment (StäB): 81
  • Hospital owners: Universitätsklinikum Tübingen AöR
  • Type of provider: öffentlich
  • University Hospital
  • Academic teaching hospital
External comparative quality assurance
Further information
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Bezeichnung
Teilnahme externe Qualitätssicherung yes
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
Quantity performed 57
Exception? No exception
Quantity performed 45
Exception? No exception
Quantity performed 73
Exception? No exception
Quantity performed 51
Exception? No exception
Quantity performed 39
Exception? No exception
Quantity performed 221
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 57
Quantity forecast year: 65
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 45
Quantity forecast year: 50
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 73
Quantity forecast year: 88
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 51
Quantity forecast year: 57
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 39
Quantity forecast year: 44
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 221
Quantity forecast year: 235
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 89
Quantity forecast year: 83
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
No. Explanation
CQ01 Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
CQ02 Quality assurance measures for the inpatient care of children and adolescents with haemato-oncological diseases
CQ05 Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1
CQ08 Measures for quality assurance of cardiac surgery care in children and adolescents according to Article 136, para. 1, sentence 1, no. 2 of the SGB V
CQ24 Quality assurance measures for allogeneic stem cell transplantation for multiple myeloma (valid until 30 June 2022)
CQ25 Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V
CQ27 Guideline on quality assurance measures for inpatient care with bronchoscopic lung volume reduction procedures for severe emphysema (QS Guideline bronchoscopic LVR /QS-RL BLVR)
CQ03 Quality assurance measures for the implementation of positron emission tomography (PET) in hospitals for the indications non-small-cell lung cancer (NSCLC) and solid pulmonary nodules
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: yes
Number Group
825 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
521 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
76 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

  • Aktualisierung in der Umsetzung
Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission

Dokumentenmanagementsystem roXtra

27.12.2022

  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
  • Fallbesprechungen
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Interaktionscheck der Medikation
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Training in other healing professions
Comment

Schule für Pflegeberufe https://www.medizin.uni-tuebingen.de/de/das-klinikum/einrichtungen/schulen/pflegeschule Bachelorstudiengang Pflege (B.Sc.) https://www.medizin.uni-tuebingen.de/de/medizinische-fakultaet/studium-und-lehre/studiengaenge/pflege

Comment

Schule für Pflegeberufe https://www.medizin.uni-tuebingen.de/de/das-klinikum/einrichtungen/schulen/pflegeschule

Comment

https://www.medizin.uni-tuebingen.de/de/das-klinikum/einrichtungen/schulen/mtar-schule

Comment

https://www.medizin.uni-tuebingen.de/de/das-klinikum/einrichtungen/schulen/ota-schule

Comment

https://www.medizin.uni-tuebingen.de/de/das-klinikum/einrichtungen/schulen/logopaedenschule

Comment

https://www.medizin.uni-tuebingen.de/de/das-klinikum/einrichtungen/schulen/hebammenschule Studiengang B.Sc. Hebammenwissenschaft (dual-primärqualifizierende) https://www.medizin.uni-tuebingen.de/de/medizinische-fakultaet/studium-und-lehre/studiengaenge/hebammenwissenschaft

Comment

https://www.medizin.uni-tuebingen.de/de/das-klinikum/einrichtungen/schulen/mtla

Comment

https://www.medizin.uni-tuebingen.de/de/das-klinikum/einrichtungen/schulen/ata-schule

Comment

Schule für Pflegeberufe https://www.medizin.uni-tuebingen.de/de/das-klinikum/einrichtungen/schulen/pflegeschule incl. Gesundheits- und Krankenpflegehilfe für Bewerberinnen und Bewerber mit Sprachniveau B1

Comment

Schule für Pflegeberufe https://www.medizin.uni-tuebingen.de/de/das-klinikum/einrichtungen/schulen/pflegeschule

Peter Häußer

Patientenfürsprecher

Geissweg 3
72076 Tübingen

Phone: 07071 -29-87379
Mail: ed.xmg@eut-gnutarebnetneitap

Ulrich Hufnagel

Patientenfürsprecher

Geissweg 3
72076 Tübingen

Phone: 07071 -29-87379
Mail: ed.xmg@eut-gnutarebnetneitap

Sabine Sauer

Patientenfürsprecherin

Geissweg 3
72076 Tübingen

Phone: 07071 -29-87379
Mail: ed.xmg@eut-gnutarebnetneitap

Vladimira Fink-Balner

Koordination Meinungsecho

Geissweg 3
72076 Tübingen

Phone: 07071 -29-87500
Mail: ed.negnibeut-inu.dem@mm

Prof. Dr. med. Dr. oec. Martin Holderried, M. Sc.

Leitung Zentralbereich Medizin

Geissweg 3
72076 Tübingen

Phone: 07071 -29-87341
Mail: ed.negnibeut-inu.dem@deirredloh.nitram

Prof. Dr. med. Michael Bamberg

Leitender Ärztlicher Direktor/Vorstandvorsitzender

Geissweg 3
72076 Tübingen

Phone: 07071 -29-88500
Mail: ed.negnibeut-inu.dem@dnatsrov

Prof. Dr. Hans-Peter Lipp

Chefapotheker

Geissweg 3
72076 Tübingen

Phone: 07071 -29-82276
Mail: ed.negnibeut-inu.dem@ppiL.reteP-snaH

Frau Andrea Geipel

Leitung Pharmazeutische Dienstleistungen

Geissweg 3
72076 Tübingen

Phone: 07071 -29-82036
Mail: ed.negnibeut-inu.dem@lepieg.aerdna

Belegungsmanager jede Klinik Vorort

Belegungsmanager

Geissweg 3
72076 Tübingen

Phone: 07071 -29-0
Mail: ed.negnibeut-inu.dem@ecivres

Geissweg 3
72076 Tübingen

Phone: 07071-29-0
Fax: 07071-29-3966
Mail: ed.negnibeut-inu.dem@ecivres

Dipl.-Kfm. Klaus Tischler

Pflegedirektor

Geissweg 3
72076 Tübingen

Phone: 07071 -29-85139
Mail: ed.negnibeut-inu.dem@dnatsrov

Dr. Renate Fuhr

Stellvertretende Pflegedirektorin

Geissweg 3
72076 Tübingen

Phone: 07071 -29-84869
Mail: ed.negnibeut-inu.dem@rhuf.etaner

Dipl.-Volksw. Gabriele Sonntag

Kaufmännische Direktorin/Stv. Vorstandsvorsitzende

Geissweg 3
72076 Tübingen

Phone: 07071 -29-82005
Mail: ed.negnibeut-inu.dem@dnatsrov

Ass. jur. Christian Anton, Dipl.-Kfm. (FH)

Stellvertretender Kaufmännischer Direktor

Geissweg 3
72076 Tübingen

Phone: 07071 -29-82014
Mail: ed.negnibeut-inu.dem@notna.naitsirhc

Prof. Dr. med. Michael Bamberg

Leitender Ärztlicher Direktor/ Vorstandsvorsitzender

Geissweg 3
72076 Tübingen

Phone: 07071 -29-88500
Mail: ed.negnibeut-inu.dem@dnatsrov

Prof. Dr. med. Michael Bamberg

Leitender Ärztlicher Direktor/Vorstandvorsitzender

Geissweg 3
72076 Tübingen

Phone: 07071 -29-88500
Mail: ed.negnibeut-inu.dem@dnatsrov

Prof. Dr. med. Karl-Ulrich Bartz-Schmidt

Stellvertretender Leitender Ärztlicher Direktor

Geissweg 3
72076 Tübingen

Phone: 07071 -29-84001
Mail: ed.negnibeut-inu.dem@dnatsrov

IK: 260840108

More IK: 260840108

Location number: 772041000

Old location number: 772041000